Third Point sues Sotheby's over Poison Pill
BOSTON, March 25
BOSTON, March 25 (Reuters) - Daniel Loeb's Third Point on Tuesday sued Sotheby's to remove restrictions that blocked the hedge fund from acquiring up to 20 percent of the auction house's stock.
"The Board rejected Third Point's request out-of-hand and continues to enforce the Poison Pill against Third Point," the hedge fund said in the suit which was filed in Delaware Chancery Court.
(Reporting by Svea Herbst-Bayliss; Editing by Richard Valdmanis)
- China food scandal spreads, drags in Starbucks, Burger King and McNuggets in Japan |
- U.S. court rulings create new uncertainty over Obamacare
- Israel pounds Gaza despite international peace efforts |
- EU readies possible capital, tech sanctions on Russia
- Train carrying MH17 bodies on final journey reaches Ukraine city |